Product References
L-2hydroxyglutaric acid rewires amino acid metabolism in colorectal cancer via the mTOR-ATF4 axis.
Oncogene
Tabata S,Kojima Y,Sakamoto T,Igarashi K,Umetsu K,Ishikawa T,Hirayama A,Kajino-Sakamoto R,Sakamoto N,Yasumoto KI,Okano K,Suzuki Y,Yachida S,Aoki M,Soga T
Sat Apr 01 00:00:00 UTC 2023
Oncometabolite d-2HG alters T cell metabolism to impair CD8+ T cell function.
Science (New York, N.Y.)
Notarangelo G,Spinelli JB,Perez EM,Baker GJ,Kurmi K,Elia I,Stopka SA,Baquer G,Lin JR,Golby AJ,Joshi S,Baron HF,Drijvers JM,Georgiev P,Ringel AE,Zaganjor E,McBrayer SK,Sorger PK,Sharpe AH,Wucherpfennig KW,Santagata S,Agar NYR,Suvà ML,Haigis MC
Fri Sep 30 00:00:00 UTC 2022
MYC, mitochondrial metabolism and O-GlcNAcylation converge to modulate the activity and subcellular localization of DNA and RNA demethylases.
Leukemia
Lin AP,Qiu Z,Ethiraj P,Sasi B,Jaafar C,Rakheja D,Aguiar RCT
Fri Apr 01 00:00:00 UTC 2022
Renal oncometabolite L-2-hydroxyglutarate imposes a block in kidney tubulogenesis: Evidence for an epigenetic basis for the L-2HG-induced impairment of differentiation.
Frontiers in endocrinology
Taub M,Mahmoudzadeh NH,Tennessen JM,Sudarshan S
Fri Sep 23 00:00:00 UTC 2022
Urinary 2-Hydroxyglutarate Enantiomers Are Markedly Elevated in a Murine Model of Type 2 Diabetic Kidney Disease.
Metabolites
Baek J,Pennathur S
Wed Jul 21 00:00:00 UTC 2021
Metabolic remodelling during early mouse embryo development.
Nature metabolism
Zhao J,Yao K,Yu H,Zhang L,Xu Y,Chen L,Sun Z,Zhu Y,Zhang C,Qian Y,Ji S,Pan H,Zhang M,Chen J,Correia C,Weiskittel T,Lin DW,Zhao Y,Chandrasekaran S,Fu X,Zhang D,Fan HY,Xie W,Li H,Hu Z,Zhang J
Fri Oct 01 00:00:00 UTC 2021
MYC Regulation of D2HGDH and L2HGDH Influences the Epigenome and Epitranscriptome.
Cell chemical biology
Qiu Z,Lin AP,Jiang S,Elkashef SM,Myers J,Srikantan S,Sasi B,Cao JZ,Godley LA,Rakheja D,Lyu Y,Zheng S,Madesh M,Shiio Y,Dahia PLM,Aguiar RCT
Thu May 21 00:00:00 UTC 2020
Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
Shelar S,Shim EH,Brinkley GJ,Kundu A,Carobbio F,Poston T,Tan J,Parekh V,Benson D,Crossman DK,Buckhaults PJ,Rakheja D,Kirkman R,Sato Y,Ogawa S,Dutta S,Velu SE,Emberley E,Pan A,Chen J,Huang T,Absher D,Becker A,Kunick C,Sudarshan S
Sat Dec 15 00:00:00 UTC 2018
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity.
Science translational medicine
Sulkowski PL,Corso CD,Robinson ND,Scanlon SE,Purshouse KR,Bai H,Liu Y,Sundaram RK,Hegan DC,Fons NR,Breuer GA,Song Y,Mishra-Gorur K,De Feyter HM,de Graaf RA,Surovtseva YV,Kachman M,Halene S,Günel M,Glazer PM,Bindra RS
Wed Feb 01 00:00:00 UTC 2017
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity.
Science translational medicine
Sulkowski PL,Corso CD,Robinson ND,Scanlon SE,Purshouse KR,Bai H,Liu Y,Sundaram RK,Hegan DC,Fons NR,Breuer GA,Song Y,Mishra-Gorur K,De Feyter HM,de Graaf RA,Surovtseva YV,Kachman M,Halene S,Günel M,Glazer PM,Bindra RS
Wed Feb 01 00:00:00 UTC 2017
L2hgdh Deficiency Accumulates l-2-Hydroxyglutarate with Progressive Leukoencephalopathy and Neurodegeneration.
Molecular and cellular biology
Ma S,Sun R,Jiang B,Gao J,Deng W,Liu P,He R,Cui J,Ji M,Yi W,Yang P,Wu X,Xiong Y,Qiu Z,Ye D,Guan KL
Sat Apr 15 00:00:00 UTC 2017
L2hgdh Deficiency Accumulates l-2-Hydroxyglutarate with Progressive Leukoencephalopathy and Neurodegeneration.
Molecular and cellular biology
Ma S,Sun R,Jiang B,Gao J,Deng W,Liu P,He R,Cui J,Ji M,Yi W,Yang P,Wu X,Xiong Y,Qiu Z,Ye D,Guan KL
Sat Apr 15 00:00:00 UTC 2017
Hypoxia-Mediated Increases in L-2-hydroxyglutarate Coordinate the Metabolic Response to Reductive Stress.
Cell metabolism
Oldham WM,Clish CB,Yang Y,Loscalzo J
Tue Aug 04 00:00:00 UTC 2015
Hypoxia-Mediated Increases in L-2-hydroxyglutarate Coordinate the Metabolic Response to Reductive Stress.
Cell metabolism
Oldham WM,Clish CB,Yang Y,Loscalzo J
Tue Aug 04 00:00:00 UTC 2015
Hypoxia Induces Production of L-2-Hydroxyglutarate.
Cell metabolism
Intlekofer AM,Dematteo RG,Venneti S,Finley LW,Lu C,Judkins AR,Rustenburg AS,Grinaway PB,Chodera JD,Cross JR,Thompson CB
Tue Aug 04 00:00:00 UTC 2015
Hypoxia Induces Production of L-2-Hydroxyglutarate.
Cell metabolism
Intlekofer AM,Dematteo RG,Venneti S,Finley LW,Lu C,Judkins AR,Rustenburg AS,Grinaway PB,Chodera JD,Cross JR,Thompson CB
Tue Aug 04 00:00:00 UTC 2015
D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth.
Oncotarget
Ma S,Jiang B,Deng W,Gu ZK,Wu FZ,Li T,Xia Y,Yang H,Ye D,Xiong Y,Guan KL
Mon Apr 20 00:00:00 UTC 2015
L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer.
Cancer discovery
Shim EH,Livi CB,Rakheja D,Tan J,Benson D,Parekh V,Kho EY,Ghosh AP,Kirkman R,Velu S,Dutta S,Chenna B,Rea SL,Mishur RJ,Li Q,Johnson-Pais TL,Guo L,Bae S,Wei S,Block K,Sudarshan S
Sat Nov 01 00:00:00 UTC 2014
L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer.
Cancer discovery
Shim EH,Livi CB,Rakheja D,Tan J,Benson D,Parekh V,Kho EY,Ghosh AP,Kirkman R,Velu S,Dutta S,Chenna B,Rea SL,Mishur RJ,Li Q,Johnson-Pais TL,Guo L,Bae S,Wei S,Block K,Sudarshan S
Sat Nov 01 00:00:00 UTC 2014
Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma.
PloS one
Krell D,Assoku M,Galloway M,Mulholland P,Tomlinson I,Bardella C
Mon Nov 28 00:00:00 UTC 2011
Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma.
PloS one
Krell D,Assoku M,Galloway M,Mulholland P,Tomlinson I,Bardella C
Mon Nov 28 00:00:00 UTC 2011